Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Stocks

Biotechnology (IBB) Gets Silver Cross BUY Signal

by May 16, 2024
May 16, 2024
Biotechnology (IBB) Gets Silver Cross BUY Signal

Today the Biotechnology ETF (IBB) 20-day EMA crossed up through the 50-day EMA (Silver Cross), generating an IT Trend Model BUY Signal. If we look “under the hood” we can see that participation continues to expand. The Silver Cross Index tells us how many stocks within this group have a 20-day EMA above the 50-day EMA or a Silver Cross. While it isn’t reading above our bullish 50% threshold, it is rising strongly above its signal line.

Primary indicators are also positive. The RSI is not yet overbought. The PMO is on a Crossover BUY Signal and is rising above the zero line. Stochastics have camped out above 80 signaling internal price strength. We should see this group continue to outperform the SPY.

The weekly chart shows a rising weekly PMO, but we do note that overhead resistance is nearing and it is strong. We could see price stumble at that level before a possible breakout.

Conclusion: Biotechs saw a Silver Cross. The participation indicators under the hood are seeing improvement and primary indicators are bullish enough to look for some upside follow through.

If you like this “under the hood” chart then you would love a subscription to DecisionPoint.com. You’ll get access to all of our “under the hood” charts that include all the major indexes, sectors and select industry groups! Use our coupon code: DPTRIAL2 and try us out for 2 weeks FREE!

Learn more about DecisionPoint.com:

Watch the latest episode of the DecisionPointTrading Room on DP’s YouTube channel here!

Try us out for two weeks with a trial subscription!

Use coupon code: DPTRIAL2 at checkout!

Technical Analysis is a windsock, not a crystal ball. –Carl Swenlin

(c) Copyright 2024 DecisionPoint.com

Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional. Any opinions expressed herein are solely those of the author, and do not in any way represent the views or opinions of any other person or entity.

DecisionPoint is not a registered investment advisor. Investment and trading decisions are solely your responsibility. DecisionPoint newsletters, blogs or website materials should NOT be interpreted as a recommendation or solicitation to buy or sell any security or to take any specific action.

Helpful DecisionPoint Links:

Trend Models

Price Momentum Oscillator (PMO)

On Balance Volume

Swenlin Trading Oscillators (STO-B and STO-V)

ITBM and ITVM

SCTR Ranking

Bear Market Rules

previous post
Rules-Based Money Management – Part 5: Security Selection, Rules, and Guidelines
next post
Larry Williams: Dow 40k, Cycle Analysis, and Lessons Learned

Related Posts

Why Stock Outperformance Might be ENDING!

September 11, 2024

The Finances Look Good For Equity Trend

November 25, 2024

Equities Set New Highs As Growth Sectors Drive...

July 8, 2024

Find Stocks That Are BEATING The S&P 500...

March 9, 2024

How to Analyze Volume Trends on Multiple Time...

March 29, 2024

Equities Remain in Strong “Go” Trend as Tech...

December 9, 2024

TECHNOLOGY AGAIN PROVIDES ONLY SPARK FOR MARKETS

June 24, 2024

Stock Market Today: Tech Tumbles as Mega-Cap Stocks...

September 4, 2024

These 4 Chinese Stocks are Worth a Look

October 2, 2024

The Bull Case for Buffett’s Biggest Holding

May 3, 2024

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Cracker Barrel assures customers its values remain the same amid logo uproar

      August 26, 2025
    • Trump battles John Bolton, Chris Christie and threatens to pull funds from Wes Moore’s Maryland

      August 26, 2025
    • Trump opens door to 600,000 Chinese students amid Beijing trade talks

      August 26, 2025
    • U.S. could take stakes in more firms, White House adviser says

      August 26, 2025
    • Epstein estate hit with new House subpoena for ‘client list,’ call logs

      August 25, 2025
    • Keurig Dr Pepper to buy Peet’s Coffee owner in $18 billion deal

      August 25, 2025

    Categories

    • Business (1,364)
    • Politics (6,851)
    • Stocks (904)
    • World News (461)
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved